Literature DB >> 9933457

Interactions of allogeneic human mononuclear cells in the two-way mixed leucocyte culture (MLC): influence of cell numbers, subpopulations and cyclosporin.

T Sato1, A Deiwick, G Raddatz, K Koyama, H J Schlitt.   

Abstract

With organ allografts considerable numbers of donor-type mononuclear cells are transferred to the recipient, leading to bilateral immunological interactions between donor and recipient lymphocytes. To study such bilateral immune reactions in detail, human two-way MLC were performed. In this model proliferation kinetics, patterns of activation, and survival of the two populations were analysed, and the relevance of initial cell subset composition, relative cell numbers, and the effect of immunosuppression on this co-culture were evaluated. It could be demonstrated that with an initial 50:50 ratio of two populations of allogeneic cells one population dominated after 21 days of co-culture in 78 out of 80 combinations (97%) tested; the other population decreased markedly after an initially stable phase of 6-7 days. With unequal starting conditions the larger population dominated when resting cells were used, but small populations of preactivated cells or separated CD8+ cells could also dominate. Depletion of CD16+ natural killer (NK) cells and of CD2- cells (B cell and monocytes) had no effect on domination. Addition of cyclosporin delayed or blocked the domination process while addition of IL-2 accelerated it. Disappearance of one population was associated with detection of apoptotic cells. The findings indicate that co-cultures of allogeneic mononuclear cells are generally not stable for more than 1 week, but lead to active elimination of one population. CD8+ cells and particularly preactivated cells seem to play the most important role in that process, while NK cells are of less importance. Cyclosporin can prolong survival of allogeneic cells in co-culture. These observations suggest that under the conditions of clinical organ transplantation even small amounts of immunocompetent donor cells transferred by the graft may persist for some time and may, thereby, have the chance to exert immunomodulatory functions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933457      PMCID: PMC1905169          DOI: 10.1046/j.1365-2249.1999.00784.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  LYMPHOCYTE INTERACTION: A POTENTIAL HISTOCOMPATIBILITY TEST IN VITRO.

Authors:  F BACH; K HIRSCHHORN
Journal:  Science       Date:  1964-02-21       Impact factor: 47.728

2.  THE DEVELOPMENT OF LARGE IMMATURE MONONUCLEAR CELLS IN MIXED LEUKOCYTE CULTURES.

Authors:  B BAIN; M R VAS; L LOWENSTEIN
Journal:  Blood       Date:  1964-01       Impact factor: 22.113

3.  Severe graft-versus-host disease in a liver-transplant recipient.

Authors:  J F Burdick; G B Vogelsang; W J Smith; E R Farmer; W B Bias; S H Kaufmann; J Horn; P M Colombani; H A Pitt; B A Perler
Journal:  N Engl J Med       Date:  1988-03-17       Impact factor: 91.245

4.  The rapid rejection of allogeneic lymphocytes by a non-adaptive, cell-mediated mechanism (NK activity).

Authors:  B Rolstad; S Fossum; H Bazin; I Kimber; J Marshall; S M Sparshott; W L Ford
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

Review 5.  Natural cytotoxicity: early killing of allogeneic lymphocytes in rats.

Authors:  B F Heslop; L J McNeilage
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

6.  An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it.

Authors:  R G Miller
Journal:  Nature       Date:  1980-10-09       Impact factor: 49.962

7.  One-way stimulation in mixed leukocyte cultures.

Authors:  F H Bach; N K Voynow
Journal:  Science       Date:  1966-07-29       Impact factor: 47.728

8.  Rapid and long-term changes to host cytotoxic T lymphocyte precursors reactive to donor antigens caused by intravenous injection of histoincompatible lymphocytes.

Authors:  D R Martin; X Sheng-Tanner; R G Miller
Journal:  Transplantation       Date:  1992-07       Impact factor: 4.939

9.  Interaction of maternal and neonatal cells in mixed-lymphocyte cultures.

Authors:  S D Lawler; E O Ukaejiofo; B R Reeves
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

10.  Graft-versus-host disease in solid organ transplantation.

Authors:  N V Jamieson; V Joysey; P J Friend; R Marcus; S Ramsbottom; T Baglin; P S Johnston; R Williams; R Y Calne
Journal:  Transpl Int       Date:  1991-06       Impact factor: 3.782

View more
  9 in total

1.  Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Athanasios Mavropoulos; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Biomed Rep       Date:  2017-09-11

2.  In human cell cultures, everolimus is inferior to tacrolimus in inhibiting cellular alloimmunity, but equally effective as regards humoral alloimmunity.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Maria Sounidaki; Georgia Antoniadi; Nikolaos Antoniadis; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Int Urol Nephrol       Date:  2017-05-15       Impact factor: 2.370

3.  Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Georgia Antoniadi; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Immunology       Date:  2015-07-27       Impact factor: 7.397

4.  Angiogenin is upregulated during the alloreactive immune response and has no effect on the T-cell expansion phase, whereas it affects the contraction phase by inhibiting CD4+ T-cell apoptosis.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Maria Sounidaki; Nikolaos Antoniadis; Georgia Antoniadi; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Exp Ther Med       Date:  2016-10-06       Impact factor: 2.447

5.  FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells.

Authors:  X Liu; S N Robinson; T Setoyama; S S Tung; L D'Abundo; M Y Shah; H Yang; E Yvon; N Shah; H Yang; M Konopleva; G Garcia-Manero; I McNiece; K Rezvani; G A Calin; E J Shpall; S Parmar
Journal:  Bone Marrow Transplant       Date:  2014-04-07       Impact factor: 5.483

6.  Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease.

Authors:  Simrit Parmar; Xiaoying Liu; Shawndeep S Tung; Simon N Robinson; Gabriel Rodriguez; Laurence J N Cooper; Hui Yang; Nina Shah; Hong Yang; Marina Konopleva; Jeffery J Molldrem; Guillermo Garcia-Manero; Amer Najjar; Eric Yvon; Ian McNiece; Katy Rezvani; Barbara Savoldo; Catherine M Bollard; Elizabeth J Shpall
Journal:  Cytotherapy       Date:  2013-10-26       Impact factor: 5.414

7.  Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo.

Authors:  Simrit Parmar; Xiaoying Liu; Amer Najjar; Nina Shah; Hong Yang; Eric Yvon; Katy Rezvani; Ian McNiece; Patrick Zweidler-McKay; Leonard Miller; Steve Wolpe; Bruce R Blazar; Elizabeth J Shpall
Journal:  Blood       Date:  2014-11-26       Impact factor: 22.113

8.  Assessment of Humoral Alloimmunity in Mixed Lymphocyte Reaction.

Authors:  Georgios Pissas; Theodoros Eleftheriadis
Journal:  Bio Protoc       Date:  2019-01-20

9.  Phenotypic and functional changes in blood monocytes following adherence to endothelium.

Authors:  Colin Tso; Kerry-Anne Rye; Philip Barter
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.